Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-24
1993-02-16
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514260, 514258, 544278, 544280, 544283, 544284, 544286, 544291, 544292, 544295, A61K 31505, C07D23914
Patent
active
051871688
ABSTRACT:
There are disclosed compounds of the general formula I: ##STR1## wherein A is --CR.sup.7 .dbd.CR.sup.8 --;
REFERENCES:
patent: 4880804 (1989-11-01), Carini et al.
Can. J. Chem. 1984, 62, 2575 Only Page 2575 Provided.
Chem. Abst. vol. 111, 232719e (1989).
Jour. Cell Biology, vol. 117(1) 157, 1992.
Garrick Lloyd M.
Primeau John L.
American Home Products Corporation
Ford John M.
Patton Walter
Venkat Jyothsna
LandOfFree
Substituted quinazolines as angiotensin II antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinazolines as angiotensin II antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazolines as angiotensin II antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2148177